Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Xeljanz Side Effects May Increase Risk of Cancer, Serious Heart Problems: FDA Alert February 5, 2021 Russell Maas Add Your Comments Following a mandatory post-marketing safety study designed to examine the side effects of Xeljanz, federal regulatory officials indicate users of Pfizer’s ulcerative colitis drug with underlying heart conditions may be more likely to develop cancer and severe cardiovascular problems. The U.S. Food and Drug Administration (FDA) issued a Xeljanz safety communication warning on February 4, alerting healthcare professionals and patients to the preliminary results from the new clinical trial, which suggests the arthritis and ulcerative colitis medicine may cause an increased risk of serious heart-related health risks and cancer. Xeljanz (tofacitinib) was the first Janus kinase inhibitor (jakinib) approved by the FDA in 2012, for treatment of adults with rheumatoid arthritis, which is an autoimmune disorder that causes inflammation of the joints in approximately 1% of the population. In 2018, the drug gained approval from the FDA to treat a serious inflammatory condition called ulcerative colitis. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION This new FDA warning was issued after initial results from a postmarketing clinical trial, which raises serious concerns about the link between Xeljanz and cancer, heart problems and other health risks. The study was required by federal regulators to examine the Xeljanz risk of pulmonary embolism and death, and interim results announced in 2019 indicated that users taking higher 10 mg twice daily doses were more likely to develop the serious blood clots in the lungs, leading the agency to require a new “black box” warning, which is the strongest label indication that can be placed on a prescription medication. “The clinical trial is now complete and initial results show a higher occurrence of serious heart-related events and cancer in rheumatoid arthritis (RA) patients treated with both doses of tofacitinib compared to patients treated with a TNF inhibitor,” the FDA warning states. “FDA is awaiting additional results from the trial.” Additional concerns raised in that initial clinical trial suggested that patients taking Xeljanz were at an increased risk for developing serious infections including tuberculosis, invasive fungal infections and bacterial and viral infections that resulted in hospitalizations and deaths. Pfizer previously announced that if a patients develops an infection while using Xeljanz, treatment should be interrupted until the infection is controlled. As Xeljanz blood clot injuries emerged, the FDA required Pfizer to conduct post-marketing safety clinical trials to reassess dosing levels and compare the rate of blood clot, cardiovascular disease, cancer development and overall mortality rates to patients taking alternative tumor necrosis factor (TNF) inhibitors. Since Xeljanz was first introduced into the market in 2012 by Pfizer Pharmaceutical Company, roughly 1% of the population is anticipated to have used or currently be using the medication. The company’s multi-purpose drug has been steadily increasing in sales each year, reaching blockbuster status with sales in excess of $1 billion per year. New Recommendations For Doctors and Patients The FDA’s warning outlines the preliminary data of the post -marketing ORAL Surveillance safety study, finding Xeljanz to be associated with a higher rate of major heart attacks and cancer in patients over 50 with underlying cardiovascular risk factors. The FDA indicates it will continue to work closely with Pfizer to evaluate the clinical trial results to obtain additional information before communicating a final conclusion and recommendation. Physicians are now being instructed to consider the benefits and risks of Xeljanz when deciding whether to prescribe or continue patients on the medicine, especially those with underlying heart conditions. Recommendations to patients warns they should not change their recommended dose or stop taking Xeljanz before consulting with their healthcare professional, as doing so could worsen their condition. Patients taking Xeljanz who begin to experience sudden shortness of breath, chest pain, difficulty breathing, coughing up blood, excessive sweating or clammy or bluish colored skin should seek immediate medical help. The FDA is encouraging health providers and patients to report adverse events related to Xeljanz and Xeljanz XR to the administration’s MedWatch Safety Information and Adverse Event Reporting Program. Even before the latest cardiovascular and cancer concerns, Pfizer faced a number of Xeljanz lawsuits filed by users of the medication who have suffered a pulmonary embolism, deep vein thrombosis (DVT), stroke or other blood clot injuries, including wrongful deaths. Tags: Heart Attacks, Pfizer, Pulmonary Embolism, Rheumatoid Arthritis, Stroke, Xeljanz Image Credit: | Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. More Xeljanz Lawsuit Stories Xeljanz Side Effects May Cause Weight Gain: Study May 22, 2025 Side Effects of Xeljanz, Rinvoq and Similar Drugs May Increase Risk of Acne: Study November 8, 2023 Cancer Risk with Xeljanz, Other JAK Inhibitors Higher Than Among Users of Older TNF Inhibitors May 1, 2023 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Brain Tumor Caused Numbness Over Half of Woman’s Body, Lawsuit Alleges (Posted: yesterday) A Depo-Provera brain tumor lawsuit indicates it took years for a woman to learn that her condition was linked to the birth control injections. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (07/25/2025)Depo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (07/15/2025) Nitrous Oxide Overdose Deaths Claimed 1,240 Lives Between 2010 and 2023: Report (Posted: 2 days ago) A new study warns that nitrous oxide overdose deaths have increased five-fold in recent years as recreational use, and abuse, has become more widespread among teens and young adults. MORE ABOUT: NITROUS OXIDE LAWSUITNitrous Oxide Abuse Crisis Fueled by Youth Marketing and Addictive Designs, Lawsuits Allege (07/16/2025)Recreational Nitrous Oxide Use Linked to Frostbite Injury Risks, Case Report Warns (07/09/2025)Nitrous Oxide Side Effects From Long-Term Use Linked to Paralysis, Nerve Damage in Lawsuits (07/02/2025) Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (Posted: 3 days ago) Talcum powder injury lawyers have been assigned to oversee settlement negotiations aiming to resolve nearly 100,000 lawsuits alleging Johnson & Johnson talc-based products can cause cancer. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSBaby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family (08/01/2025)Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (07/03/2025)Talcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)
Cancer Risk with Xeljanz, Other JAK Inhibitors Higher Than Among Users of Older TNF Inhibitors May 1, 2023
Depo-Provera Brain Tumor Caused Numbness Over Half of Woman’s Body, Lawsuit Alleges (Posted: yesterday) A Depo-Provera brain tumor lawsuit indicates it took years for a woman to learn that her condition was linked to the birth control injections. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (07/25/2025)Depo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (07/15/2025)
Nitrous Oxide Overdose Deaths Claimed 1,240 Lives Between 2010 and 2023: Report (Posted: 2 days ago) A new study warns that nitrous oxide overdose deaths have increased five-fold in recent years as recreational use, and abuse, has become more widespread among teens and young adults. MORE ABOUT: NITROUS OXIDE LAWSUITNitrous Oxide Abuse Crisis Fueled by Youth Marketing and Addictive Designs, Lawsuits Allege (07/16/2025)Recreational Nitrous Oxide Use Linked to Frostbite Injury Risks, Case Report Warns (07/09/2025)Nitrous Oxide Side Effects From Long-Term Use Linked to Paralysis, Nerve Damage in Lawsuits (07/02/2025)
Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (Posted: 3 days ago) Talcum powder injury lawyers have been assigned to oversee settlement negotiations aiming to resolve nearly 100,000 lawsuits alleging Johnson & Johnson talc-based products can cause cancer. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSBaby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family (08/01/2025)Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (07/03/2025)Talcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)